Meet some of our researchers

How do leukemic subclones respond to chemotherapy? Hans Beier Ommen uses monitoring techniques to investigate this question.

Read about Hans Beier Ommen

Iben Lyskjær’s research is focused on finding better ways to identify and treat high-risk kidney cancer patients.

Read about Iben Lyskjær

Sarcoma patients and patients with other rare cancers often experience that nobody knows about their disease and they often feel set aside for the more common cancers.

Read about Ninna Aggerholm-Pedersen